Photo of Yang Li

Dr. Yang (Alex) Li is an associate in the Intellectual Property Practice Group in the firm's Washington, D.C. office.

December 7, 2023, President Biden announced new actions to promote competition in health care and to lower prescription drug costs. Of particular note is a newly unveiled framework for deciding whether the Government may exercise “march-in” rights and take a pharmaceutical company’s drug patents developed with federal funds and share them with other companies. See Draft Interagency Guidance Framework for Considering the Exercise of March-In Rights, available here (“Draft Guidance”).Continue Reading The March on Pharmaceutical Patents?